A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Clinical trial NCT06037252 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06037252
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2026-01-08
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.